Guselkumab (an IL-23–specific mAb) demonstrates clinical and molecular response in patients with moderate-to-severe psoriasis
- Resource Type
- Article
- Authors
- Sofen, Howard; Smith, Stacy; Matheson, Robert T.; Leonardi, Craig L.; Calderon, Cesar; Brodmerkel, Carrie; Li, Katherine; Campbell, Kim; Marciniak, Stanley J., Jr.; Wasfi, Yasmine; Wang, Yuhua; Szapary, Philippe; Krueger, James G.
- Source
- In The Journal of Allergy and Clinical Immunology April 2014 133(4):1032-1040
- Subject
- Language
- ISSN
- 0091-6749